Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BWV

Onconetix (BWV) Stock Price, News & Analysis

Onconetix logo

About Onconetix Stock (NASDAQ:BWV)

Advanced Chart

Key Stats

Today's Range
$76.89
$77.50
50-Day Range
$0.18
$0.18
52-Week Range
$0.18
$1.95
Volume
1,999 shs
Average Volume
795,235 shs
Market Capitalization
$1.45 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Blue Water Biotech, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns ENTADFI, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Vaccines, Inc. and changed its name to Blue Water Biotech, Inc. in April 2023. Blue Water Biotech, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

Receive BWV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Onconetix and its competitors with MarketBeat's FREE daily newsletter.

BWV Stock News Headlines

BWV Blue Water Biotech, Inc.
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Blue Water Biotech Acquires Proteomedix AG
Blue Water Biotech Inc.
See More Headlines

BWV Stock Analysis - Frequently Asked Questions

Onconetix (BWV) raised $20 million in an IPO on Friday, February 18th 2022. The company issued 2,222,222 shares at $9.00 per share.

Company Calendar

Today
5/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:BWV
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$13.42 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.63 per share
Price / Book
47.55

Miscellaneous

Free Float
15,017,000
Market Cap
$1.45 billion
Optionable
Not Optionable
Beta
3.58
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:BWV) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners